TS

Tripti Sapra

Active Director Additional Director DIN 10776278
DIN 10776278 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Oct 2024
Shareholding value •••• Premium profile

About Tripti Sapra

Data last updated:

Tripti Sapra is an Additional Director at Baxter Pharmaceuticals India Private Limited (since 2024), Director at Baxter Pharmaceuticals India Private Limited (since 2024) and Additional Director at Baxter India Private Limited (since 2024). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹1,848 Cr; the largest is Baxter Pharmaceuticals India Private Limited at ₹672 Cr (FY 2025).

DIN 10776278
Primary Designation Additional Director
Industry Pharma
First Appointment 01 Oct 2024
Oldest Company Age 30 yrs
Largest company Baxter Pharmaceuticals India Private Limited · ₹672 Cr (FY 2025)
Combined revenue ₹1,848 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director01 Oct 20242005₹672 Cr (FY 2025)Active
Director01 Oct 20242005₹672 Cr (FY 2025)Active
Baxter India Private Limited U33112HR1996PTC038528
Additional Director15 Oct 20241996₹505 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Baxter Pharmaceuticals India Private Limited
Baxter India Private Limited
Baxter Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Tripti Sapra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tripti Sapra

Tripti Sapra currently holds 3 directorships: Baxter Pharmaceuticals India Private Limited (Additional Director, since 01 Oct 2024, revenue ₹672 Cr (FY 2025)); Baxter Pharmaceuticals India Private Limited (Director, since 01 Oct 2024, revenue ₹672 Cr (FY 2025)); Baxter India Private Limited (Additional Director, since 15 Oct 2024, revenue ₹505 Cr (FY 2024)).

Tripti Sapra was first appointed on 01 Oct 2024 as Additional Director at Baxter Pharmaceuticals India Private Limited.

The 3 current companies of Tripti Sapra that report revenue have a combined latest revenue of ₹1,848 Cr: Baxter Pharmaceuticals India Private Limited ₹672 Cr (FY 2025); Baxter Pharmaceuticals India Private Limited ₹672 Cr (FY 2025); Baxter India Private Limited ₹505 Cr (FY 2024).

The current boards of Tripti Sapra's companies include Anurag Bharatkumar Pachchigar (Baxter Pharmaceuticals India Private Limited), Anuranjan Naresh (Baxter Pharmaceuticals India Private Limited), Ashwin Prakash Upasane (Baxter Pharmaceuticals India Private Limited), Gurjeet Singh Bedi (Baxter Pharmaceuticals India Private Limited), Sanju Dhawan (Baxter Pharmaceuticals India Private Limited), Ajay Bijani (Baxter India Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available